Hade, I. M. (2026) “A Repurposed Drug Combination Overcomes Paclitaxel Resistance and Minimizes Toxicity via Dual Metabolic and pH Modulation in Breast Cancer”, Asian Pacific Journal of Cancer Biology, 11(4), pp. 1043–1061. doi: 10.31557/APJCB.2026.11.4.1043.